Page 147 - HIV/AIDS Guidelines

12. Althoff KN, Justice AC, Gange SJ, et al. Virologic and immunologic response to HAART, by age and regimen class.
AIDS. Oct 23 2010;24(16):2469-2479.

13. Bosch RJ, Bennett K, Collier AC, Zackin R, Benson CA. Pretreatment factors associated with 3-year (144-week) virologic
and immunologic responses to potent antiretroviral therapy. J Acquir Immune Defic Syndr. Mar 1 2007;44(3):268-277.

14. Nogueras M, Navarro G, Anton E, et al. Epidemiological and clinical features, response to HAART, and survival in HIV-
infected patients diagnosed at the age of 50 or more. BMC Infect Dis. 2006;6:159.

15. Sitar DS. Aging issues in drug disposition and efficacy. Proc West Pharmacol Soc. 2007;50:16-20.
16. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: "There's got to be a happy medium."
JAMA. Oct 13 2010;304(14):1592-1601.
17. Marzolini C, Back D, Weber R, et al. Ageing with HIV: medication use and risk for potential drug-drug interactions. J
Antimicrob Chemother. Sep 2011;66(9):2107-2111.
18. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking
beyond cost and regimen complexity. Am J Geriatr Pharmacother. Feb 2011;9(1):11-23.
19. Wellons MF, Sanders L, Edwards LJ, Bartlett JA, Heald AE, Schmader KE. HIV infection: treatment outcomes in older
and younger adults. J Am Geriatr Soc. Apr 2002;50(4):603-607.
20. Wutoh AK, Elekwachi O, Clarke-Tasker V, Daftary M, Powell NJ, Campusano G. Assessment and predictors of
antiretroviral adherence in older HIV-infected patients. J Acquir Immune Defic Syndr. Jun 1 2003;33(Suppl 2):S106-114.
21. Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP, Jr. Older age and the response to and
tolerability of antiretroviral therapy. Arch Intern Med. Apr 9 2007;167(7):684-691.

22. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep. May 2010;7(2):69-76.
23. Palella FJ, Jr., Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes
of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. Sep 2006;43(1):27-34.
24. Smit C, Geskus R, Walker S, et al. Effective therapy has altered the spectrum of cause-specific mortality following HIV
seroconversion. AIDS. Mar 21 2006;20(5):741-749.
25. Kochanek KD, Xu J, Murphy SL, Minino AM, King HC. Deaths: Preliminary data for 2009. National Vital Statistics
Reports. 2011;59(4):1-54.
26. Vance DE, Wadley VG, Crowe MG, Raper JL, Ball KK. Cognitive and everyday functioning in older and younger adults
with and without HIV. Clinical Gerontologists 2011;34(5):413-426.
27. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with
the general population. Clin Infect Dis. Dec 2011;53(11):1120-1126.
28. Capeau J. Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses.
Clin Infect Dis. Dec 2011;53(11):1127-1129.
29. Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin
Infect Dis. Dec 2011;53(11):1130-1139.
30. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human
immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.
Clin Infect Dis. Sep 1 2009;49(5):651-681.
31. Henry K. Internal medicine/primary care reminder: what are the standards of care for HIV-positive patients aged 50
years and older? Curr HIV/AIDS Rep. Aug 2009;6(3):153-161.
32. American Academy of HIV Medicine. The HIV and Aging Consensus Project: Recommended treatment strategies for
clinicians managing older patients with HIV. http://www.aahivm.org/Upload_Module/upload/HIV and Aging/Aging
report working document FINAL.pdf. 2011.

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents I-31

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.